MENU
+Compare
BEAT
Stock ticker: NASDAQ
AS OF
Apr 4, 04:57 PM (EDT)
Price
$1.69
Change
-$0.14 (-7.65%)
Capitalization
57.13M

BEAT Heartbeam Forecast, Technical & Fundamental Analysis

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting... Show more

BEAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BEAT with price predictions
Apr 03, 2025

BEAT sees MACD Histogram crosses below signal line

BEAT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 03, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 27 instances where the indicator turned negative. In of the 27 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BEAT as a result. In of 59 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BEAT moved below its 50-day moving average on March 10, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BEAT entered a downward trend on March 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BEAT's RSI Oscillator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 45 cases where BEAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAT advanced for three days, in of 141 cases, the price rose further within the following month. The odds of a continued upward trend are .

BEAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BEAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.586) is normal, around the industry mean (30.907). P/E Ratio (149.254) is within average values for comparable stocks, (159.445). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.707). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (5.999) is also within normal values, averaging (59.276).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
BEAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BEAT is expected to report earnings to fall 78.77% to -15 cents per share on May 08

Heartbeam BEAT Stock Earnings Reports
Q1'25
Est.
$-0.16
Q4'24
Missed
by $0.56
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.02
Q1'24
Missed
by $0.02
The last earnings report on March 13 showed earnings per share of -73 cents, missing the estimate of -17 cents. With 143.16K shares outstanding, the current market capitalization sits at 57.13M.
A.I. Advisor
published General Information

General Information

a wireless medical technology company, which focuses on the delivery of health information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2118 Walsh Avenue
Phone
+1 408 899-4443
Employees
15
Web
https://www.heartbeam.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IAG6.530.06
+0.93%
IAMGold Corp
BEP22.46-0.11
-0.49%
Brookfield Renewable Partners LP
PMVP1.00-0.01
-0.50%
PMV Pharmaceuticals
AUDC8.96-0.64
-6.67%
AudioCodes Ltd
BA150.91-17.65
-10.47%
Boeing Company

BEAT and Stocks

Correlation & Price change

A.I.dvisor tells us that BEAT and WIX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEAT and WIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAT
1D Price
Change %
BEAT100%
-6.63%
WIX - BEAT
31%
Poorly correlated
-5.99%
ALKT - BEAT
29%
Poorly correlated
-6.50%
FICO - BEAT
28%
Poorly correlated
-4.70%
PDFS - BEAT
28%
Poorly correlated
-8.77%
EVCM - BEAT
27%
Poorly correlated
-6.15%
More